FDA Inspection 1117578 — Telix IsoTherapeutics Group, Inc.
The FDA completed an inspection of Telix IsoTherapeutics Group, Inc. on February 3, 2020 in Angleton, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 3, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Angleton, TX (United States)